Compare ALLY & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALLY | MEDP |
|---|---|---|
| Founded | 1919 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.3B | 11.7B |
| IPO Year | 2011 | 2016 |
| Metric | ALLY | MEDP |
|---|---|---|
| Price | $43.34 | $419.26 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 12 |
| Target Price | $54.42 | ★ $473.17 |
| AVG Volume (30 Days) | ★ 3.2M | 455.2K |
| Earning Date | 04-17-2026 | 04-22-2026 |
| Dividend Yield | ★ 2.74% | N/A |
| EPS Growth | ★ 31.67 | 20.98 |
| EPS | 2.37 | ★ 4.28 |
| Revenue | ★ $7,914,000,000.00 | N/A |
| Revenue This Year | $24.30 | $13.19 |
| Revenue Next Year | $4.31 | $7.75 |
| P/E Ratio | ★ $18.70 | $98.09 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $32.28 | $284.10 |
| 52 Week High | $47.27 | $628.92 |
| Indicator | ALLY | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 53.42 | 36.57 |
| Support Level | $37.23 | $382.68 |
| Resistance Level | $46.83 | $485.13 |
| Average True Range (ATR) | 1.18 | 17.47 |
| MACD | -0.15 | -10.02 |
| Stochastic Oscillator | 29.25 | 27.75 |
Formerly the captive financial arm of General Motors, Ally Financial became an independent publicly traded firm in 2014 and is one of the largest consumer auto lenders in the country. While the firm has expanded its product offerings over time, it remains primarily focused on auto lending, with more than 70% of its loan book in consumer auto loans and dealer financing. Ally also offers auto insurance, commercial loans, credit cards, and holds a portfolio of mortgage debt, giving the bank a diversified business model, which includes brokerage services.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.